In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entellus Medical Inc. (NASDAQ:ENTL) reported that Discovery Group I, Llc. has picked up 1,638,127 of common stock as of 2017-03-14.
The acquisition brings the aggregate amount owned by Discovery Group I, Llc. to a total of 1,638,127 representing a 7.5% stake in the company.
For those not familiar with the company, Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company’s XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.
A glance at Entellus Medical Inc. (NASDAQ:ENTL)’s key stats reveals a current market capitalization of 285.18 Million based on 21.88 Million shares outstanding and a price at last close of $13.10 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-02-03, Split picked up 352,941 at a purchase price of $17.00. This brings their total holding to 3,156,731 as of the date of the filing.
On the sell side, the most recent transaction saw Essex unload 16,521 shares at a sale price of $17.00. This brings their total holding to 91,808.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Entellus Medical Inc. (NASDAQ:ENTL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
